1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Inappropriate ADH Syndrome: new trials by email Literature Review of Inappropriate ADH Syndrome trials Research Report on Inappropriate ADH Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia Empagliflozin 25 MG, Placebo - Hyponatremia, SIADH | Phase 4 | Completed | University Hospital, Basel, Switzerland | 113 | 2021-02-04 | 2026-09-22 |
Hyponatremia (1) · Liver Failure (1) · Renal Insufficiency (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Hepatic Insufficiency (1) · Hypothalamic Diseases (1) · Kidney Diseases (1) · Liver Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nervous System Diseases (1) · Nutritional and Metabolic Diseases (1) · Pituitary Diseases (1)
empagliflozin (1)
University Hospital, Basel, Switzerland (1)
Germany (1) · Netherlands (1) · Switzerland (1)